Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study

Ambulatory hemodynamic monitoring with an implantable pulmonary artery (PA) sensor is approved for patients with New York Heart Association Class III heart failure (HF) and a prior HF hospitalization (HFH) within 12 months. The objective of this study was to assess the efficacy and safety of PA pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Shavelle, David M., Desai, Akshay S., Abraham, William T., Bourge, Robert C., Raval, Nirav, Rathman, Lisa D., Heywood, J. Thomas, Jermyn, Rita A., Pelzel, Jamie, Jonsson, Orvar T., Costanzo, Maria Rosa, Henderson, John D., Brett, Marie-Elena, Adamson, Philip B., Stevenson, Lynne W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434214/
https://www.ncbi.nlm.nih.gov/pubmed/32757642
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.119.006863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434214/
https://www.ncbi.nlm.nih.gov/pubmed/32757642
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.119.006863

Ejemplares similares